Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Beyond Air Receives FDA Breakthrough Device Designation For LungFit GO In NTM-PD

31 August 2026 · By · Wire by Fusion42

Published

31 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at rttnews.com →

◆ Verified

Fusion42 · 31 August 2026 · Fusion42 review

Beyond Air has received the FDA Breakthrough Device Designation for its LungFit GO device aimed at treating NTM-PD, accelerating its regulatory review process in the United States.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

This FDA designation cuts your pathway to market in US respiratory medtech, speeding patient access and creating a stronger competitive stance in lung disease devices.

◆ Coverage

1 source · 31 Aug 2026

◆ Related on Wire

◆ Topics

Medtechfdabreakthrough-devicelungfit-gontm-pdmedtech